● Chairman of the Science and Technology Strategic Committee at Jiuzhou Pharmaceutical

● PhD in Organic Synthesis from Cornell University, USA

● Editor-in-Chief of the American Chemical Society's journal Organic Process Research & Development (OPR&D)

● Approximately 37 years of experience in new drug design and process development

● Contributed to the commercialization of several commercial products, such as Crixivan, Arxocia, Aprepitant, Firocoxib, and the catalyst Phanephos, as well as the discovery and commercialization of new routes for Fexofenadine

● Head of Peptide and Oligonucleotide Business for Innovative Drug CDMO at Jiuzhou Pharmaceutical

● PhD in Biochemistry and Molecular Biology from the University of Florida, Gainesville

● Over 34 years of specialized experience in the design, development, and synthesis of peptide NCEs (New Chemical Entities)

● Has published more than 140 papers on peptide-related topics and molecular biology methods

● Vice General Manager of jiuzhou pharma (Singapore)

● PhD in Cell and Molecular Biology from Nanyang Technological University, Singapore

● Over 20 years of professional experience in cell therapy and reagent diagnostics development

● R&D Director at Jiuzhou Pharmaceuticals Germany

● PhD in Organic Synthesis from Durham University, UK

● Over 10 years of experience in organic synthesis and process development

● Responsible for establishing a research and development service platform and leading them to provide the best services and products for customers.

● Postdoc, University of Calgary
● High-level Talent in Zhejiang
● Published more than 20 papers in SCI-indexed journals
● Focuses on development of small-molecule drugs and development and applications of green chemistry processes, with 30 years of experience in organic synthesis and drug synthesis; Developed green synthetic routes for more than 30 APIs and more than 2,000 small-molecule compounds, and undertook multiple major national and provincial research projects.

● Postdoc, Columbia University
● High-level Talent in Zhejiang; Leader of the Leading Innovation and Entrepreneurship Team of Zhejiang Province
● Professor-level Senior Engineer
● More than 20 years of experience in API process development and production, particularly in the development and industrialization of green synthesis technologies, such as chiral catalysis, fluorine chemistry, continuous flow reactions, and enzyme catalysis

● Postdoc, Peking University
● Professor and Doctoral Advisor, China Pharmaceutical University
● External Reviewer, Center for Drug Evaluation (CDE) of the National Medical Products Administration
● Published more than 40 papers in SCI-indexed journals
● First prize winner of the Jiangsu Science and Technology Progress Award
● Nearly 30 years of research on DPs and their quality and pharmacokinetics; extensive research on new dosage forms and technologies for DPs to address the challenges in DP industrialization and standard determination

● Shanghai Youth Science and Technology Rising Star, Innovative Talent of Taizhou's 500 Elite Plan
● Published 10 papers in SCI-indexed journals and filed 7 patent applications
● Over 20 years of experience in drug development and production management; involved in process safety assessments for over 500 scale-up projects